Lv2
126 积分 2023-03-04 加入
Biologic therapies for severe asthma with type 2 inflammation: current evidence, patient selection, and future perspectives
20天前
已完结
Asthma exacerbations on benralizumab are largely non‐eosinophilic
1个月前
已完结
A real-world study on tezepelumab effectiveness in severe asthma focusing on small airway dysfunction
1个月前
已完结
Dual biologic therapy with mepolizumab a novel solution to dupilumab-induced conjunctivitis
1个月前
已关闭
Successful concomitant therapy with mepolizumab and dupilumab for atypical eosinophilic granulomatosis with polyangiitis
1个月前
已完结
Hypereosinophilia with systemic manifestations under dupilumab and possibility of dual benralizumab and dupilumab therapy in patients with asthma and CRSwNP
1个月前
已完结
Eosinophilic vasculitis associated with persistent dupilumab-induced hypereosinophilia in severe asthma
1个月前
已完结
Switching between biologics in severe asthma patients. When the first choice is not proven to be the best
1个月前
已完结
Asthma biologics
1个月前
已完结
Variability in Asthma Inflammatory Phenotype in Induced Sputum. Frequency and Causes
2个月前
已完结
皖公网安备34019202002308
